KalVista Pharmaceuticals, Inc.
Total Trades
184
Buys
8
Sells
92
Largest Trade
N/A
Insiders
9
Institutional Funds
118
Inst. Value
$1M+
Activist Filings
50
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Yea Christopher | CHIEF DEVELOPMENT … | GRANT | N/A | 60K | — | Jul 11, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $100K–$500K | 30K | $15.69 | Jul 11, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 7K | $14.50 | Jun 10, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 16K | — | Jun 10, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | May 27, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $11.31 | May 27, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 3K | — | May 27, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 2K | $11.31 | May 27, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 6K | — | May 23, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 3K | $11.88 | May 23, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 2K | $11.88 | May 23, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 4K | — | May 23, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 23K | — | May 23, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 10K | $11.88 | May 23, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 3K | $11.84 | May 20, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 4K | — | May 20, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $15K–$50K | 4K | $11.84 | May 20, 2025 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 9K | — | May 20, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 6K | — | May 20, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 3K | $11.84 | May 20, 2025 |
| Venrock Healthcare Capital Partners III, L.P. | 10% Owner | BUY | $100K–$500K | 25K | $9.42 | Apr 11, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | Feb 26, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $10.02 | Feb 26, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 3K | — | Feb 26, 2025 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 2K | $10.02 | Feb 26, 2025 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | Nov 28, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $9.87 | Nov 28, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 3K | — | Nov 28, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 2K | $9.87 | Nov 28, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 14K | $9.26 | Nov 20, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 30K | — | Nov 20, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $50K–$100K | 7K | $9.26 | Nov 20, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 11K | — | Nov 20, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 8K | $9.26 | Nov 20, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 19K | — | Nov 20, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $15K–$50K | 2K | $12.40 | Aug 27, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 5K | — | Aug 27, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $15K–$50K | 2K | $12.40 | Aug 26, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 3K | — | Aug 26, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | EXERCISE | N/A | 19K | — | Aug 22, 2024 |
| Audhya Paul K. | CHIEF MEDICAL OFFI… | SELL | $50K–$100K | 8K | $12.01 | Aug 22, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $100K–$500K | 14K | $12.01 | Aug 22, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 30K | — | Aug 22, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | SELL | $50K–$100K | 7K | $12.01 | Aug 22, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 11K | — | Aug 22, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | SELL | $50K–$100K | 7K | $11.53 | Jun 10, 2024 |
| Palleiko Benjamin L | CHIEF EXECUTIVE OF… | EXERCISE | N/A | 16K | — | Jun 10, 2024 |
| Feener Edward P. | CHIEF SCIENTIFIC O… | SELL | $100K–$500K | 28K | $14.07 | Feb 22, 2024 |
| Feener Edward P. | CHIEF SCIENTIFIC O… | EXERCISE | N/A | 19K | — | Feb 22, 2024 |
| Yea Christopher | CHIEF DEVELOPMENT … | EXERCISE | N/A | 19K | — | Feb 22, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 118 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VR Adviser, LLC | 6.7M | $1M+ | SH |
| Frazier Life Sciences Management, L.P. | 5.0M | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 4.6M | $1M+ | SH |
| Capital World Investors | 2.8M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 2.4M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.3M | $1M+ | SH |
| STATE STREET CORP | 1.9M | $1M+ | SH |
| EMERALD ADVISERS, LLC | 1.3M | $1M+ | SH |
| Octagon Capital Advisors LP | 1.3M | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.2M | $1M+ | SH |
| EMERALD MUTUAL FUND ADVISERS TRUST | 855K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 818K | $1M+ | SH |
| BARCLAYS PLC | 700K | $1M+ | SH |
| Squadron Capital Management LLC | 700K | $1M+ | SH |
| Freestone Grove Partners LP | 633K | $1M+ | SH |
| Spruce Street Capital LP | 388K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 382K | $1M+ | SH |
| Bank of New York Mellon Corp | 377K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 360K | $1M+ | SH |
| Blue Owl Capital Holdings LP | 360K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Point72 Asset Management, L.P.
SC 13G/A · Jan 13, 2026
5.5%
2.8M shares
Point72 Asset Management, L.P.
SC 13G · Jan 12, 2026
4.9%
2.5M shares
Integrated Core Strategies (US) LLC
SC 13G/A · Dec 30, 2025
5.1%
2.6M shares
SC 13G/A · Nov 14, 2025
1.5%
750K shares
SC 13G · Nov 10, 2025
5.0%
2.5M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Nov 4, 2025
6.9%
3.5M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Aug 20, 2025
4.8%
2.4M shares
SC 13G/A · May 15, 2025
9.9%
4.9M shares
SC 13G/A · May 13, 2025
6.4%
3.2M shares
SC 13G/A · Nov 14, 2024
10.0%
4.3M shares
Suvretta Capital Management, LLC
SC 13G/A · Nov 14, 2024
10.0%
4.3M shares
SC 13G · Nov 14, 2024
9.3%
4.0M shares
Capital World Investors 95-1411037
SC 13G · Nov 13, 2024
7.8%
3.4M shares
SC 13G/A · Nov 12, 2024
5.0%
2.2M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
3.3%
1.4M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · Nov 7, 2024
4.9%
2.4M shares
SC 13G/A · Nov 4, 2024
5.0%
2.2M shares
SC 13D/A · Apr 1, 2024
3.2%
1.3M shares
SC 13G · Feb 26, 2024
6.9%
2.8M shares
Frazier Life Sciences Public Fund, L.P. 2.
SC 13D/A · Feb 22, 2024
3.6%
1.5M shares
SC 13D/A · Feb 20, 2024
6.5%
2.7M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Feb 15, 2024
14.0%
4.8M shares
SC 13G/A · Feb 14, 2024
10.0%
3.4M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2024
7.8%
2.7M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
1.8M shares
Saturn V Capital Management LP
SC 13G · Feb 13, 2024
4.1%
1.4M shares
SC 13G · Jan 29, 2024
6.5%
2.2M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G/A · Dec 28, 2023
10.3%
3.6M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Dec 14, 2023
4.2%
1.5M shares
Suvretta Capital Management, LLC
SC 13G · Mar 10, 2023
5.3%
1.8M shares
SC 13G/A · Feb 14, 2023
3.1%
1.1M shares
SC 13G/A · Feb 14, 2023
9.4%
3.2M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 13, 2023
0.2%
83 shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2023
3.1%
1.1M shares
SC 13G/A · Jan 31, 2023
0.0%
0 shares
SC 13D · Jan 9, 2023
9.9%
3.4M shares
Venrock Healthcare Capital Partners III, L.P.
SC 13G · Jan 9, 2023
8.6%
2.9M shares
SC 13G/A · Jan 6, 2023
4.6%
1.6M shares
Frazier Life Sciences Public Fund, L.P.
SC 13D/A · Dec 30, 2022
3.8%
1.3M shares
SC 13G/A · Aug 15, 2022
0.0%
0 shares
SC 13G · May 26, 2022
5.7%
1.4M shares
SC 13G · May 18, 2022
5.2%
1.3M shares
SC 13G/A · Feb 14, 2022
0.2%
37K shares
SC 13G/A · Feb 14, 2022
7.9%
1.9M shares
Eventide Asset Management, LLC
SC 13G/A · Feb 14, 2022
0.6%
139K shares
SC 13G/A · Feb 14, 2022
6.1%
1.5M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 11, 2022
7.1%
1.7M shares
SC 13G/A · Feb 11, 2022
4.8%
1.2M shares